Metoclopramide Medical Valley (Metoclopramide Hydrochloride Monohydrate)

Metoclopramide, the active ingredient in Metoclopramide Medical Valley, is a dopamine D2 receptor antagonist presented as an oral tablet for oral use. It is employed to control nausea and vomiting, to improve gastric emptying in gastroparesis, and to aid patients receiving chemotherapy in adult patients.

GNH USA supplies Metoclopramide Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards, offers full regulatory documentation, and supports export logistics for reliable global distribution.

Metoclopramide is an antiemetic and gastroprokinetic used to treat conditions involving nausea, vomiting, and delayed gastric emptying. - Nausea and vomiting: reduces the frequency and severity of episodes in postoperative, migraine, and other acute settings. - Gastroparesis: enhances gastric motility to improve stomach emptying and alleviate related symptoms. - Gastroesophageal reflux disease (GERD): assists in symptom control by promoting faster gastric emptying. - Chemotherapy‑induced nausea and vomiting: prevents or lessens nausea associated with cytotoxic treatments.

Metoclopramide may cause a range of adverse reactions. Patients should be aware of both frequent and less common events.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: a sense of inner tension or inability to stay still. - Diarrhea: loose or watery stools. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Tardive dyskinesia: involuntary, repetitive movements that may be irreversible. - Neuroleptic malignant syndrome: a life‑threatening reaction with fever and muscle rigidity. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hyperprolactinemia: elevated prolactin levels causing hormonal disturbances. - Seizures: convulsive episodes, particularly in predisposed individuals.

Before prescribing Metoclopramide, clinicians should consider several safety measures. - Renal function assessment: adjust use in patients with impaired kidney function. - Extrapyramidal monitoring: watch for signs of muscle rigidity or involuntary movements. - Duration limitation: use the lowest effective dose for the shortest necessary period. - Hypersensitivity check: avoid in individuals with known allergy to metoclopramide. - Contraindication review: do not use in patients with gastrointestinal obstruction or perforation. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Metoclopramide can affect, and be affected by, other medicines. Interactions are grouped by clinical significance.

Major Interactions (Avoid): - CNS depressants (e.g., barbiturates, benzodiazepines): may enhance sedation and respiratory depression. - MAO inhibitors: increase risk of hypertensive crisis and serotonin syndrome. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): raise metoclopramide plasma concentrations.

Moderate Interactions (Monitor Closely): - Opioids: additive effect on gastrointestinal motility and potential for increased side effects. - Antihistamines: may potentiate drowsiness and anticholinergic effects.